About Aevitas
Overview
Aevitas is a financial institution based in Hong Kong, registered on February 7, 2020. The company operates under the official domain avss.com.hk and provides a range of investment services including stocks, bonds, mutual funds, futures contracts, and alternative investments. According to regulatory records, Aevitas holds a Derivatives Trading License (AGN) from the Securities and Futures Commission (SFC) of Hong Kong. The registered address is Room 5801C, 58 Floor, Cheung Kong Centre, Central, Hong Kong.
Despite being registered in 2020, the company description claims a founding year of 2003, which may refer to an earlier parent entity or rebranding. FXCanary notes that independent public information about Aevitas is limited, and there are no user reviews or extensive third-party analyses available at this time. This scarcity of publicly verifiable data warrants caution for potential clients.
Regulation and Licensing
Aevitas is regulated by the Securities and Futures Commission (SFC) in Hong Kong, holding a Derivatives Trading License (AGN). The SFC is a respected regulatory body overseeing securities and futures markets in Hong Kong. The licence authorizes the firm to engage in derivatives trading, which includes futures contracts and possibly other leveraged products.
However, the specific status of the SFC licence is marked as '—' in our records, indicating that details such as whether it is active or subject to any restrictions could not be confirmed. Traders should verify the licence status directly with the SFC's public register. The absence of a clear licence status, combined with the lack of user feedback, adds to the guarded risk assessment.
Products and Services
Aevitas offers a diversified portfolio of investment products including stocks, bonds, mutual funds, futures contracts, and alternative investments. This broad range suggests the broker caters to investors seeking exposure to traditional asset classes as well as more sophisticated instruments like futures.
The company claims to provide a proprietary web-based platform for trading and account management. No information is available about specific account types, minimum deposits, leverage ratios, or fee structures, as the official website (avss.com.hk) was not accessible or did not provide sufficient detail in our public search. The lack of transparent pricing and account details is a significant gap for potential clients.
Platform and Technology
According to the company description, Aevitas utilizes a proprietary web-based platform. This suggests that clients access trading and account services through a bespoke online interface rather than popular third-party platforms like MetaTrader 4/5. The absence of widely-used trading platforms may be a drawback for retail traders accustomed to advanced charting and automated trading tools.
No further details on platform features, mobile accessibility, or order execution are available from public sources. The reliance on a proprietary system without independent reviews raises questions about the platform's reliability and user experience.
Target Audience
Based on the product offering, Aevitas appears to target both retail and institutional investors who are interested in traditional securities and futures trading. The inclusion of alternative investments may appeal to high-net-worth individuals or sophisticated investors seeking portfolio diversification.
However, the lack of information about the broker's client service, educational resources, and trading conditions makes it difficult to assess its suitability for beginners or active traders. The broker does not appear to focus on forex or CFD trading, which are common among retail forex brokers. Instead, its product mix aligns more with a conventional stockbroker or wealth management firm.
Overview compiled by FXCanary from regulatory records and public data. full Aevitas review